honeywell AND sydion Announce solution for MOBILE h1n1 vaccine administration

Honeywell has announced that Sydion, LCC, a mobile crisis management technology company, is offering its patient-tracking software on Honeywells mobility platform to assist in the administration of the H1N1 vaccine.

The system that Sydion is offering bundles Honeywells Dolphin 9900 mobile computers into Sydions eMET, an emergency patient tracking system, to deliver a complete offering that enables healthcare providers to effectively prepare for and manage mass H1N1 vaccine administration at locations such as hospitals, vaccination clinics or schools.

Recently made available to the public, the H1N1 vaccine is in extremely high demand due to several outbreaks of the H1N1 flu, commonly known as the swine flu. The mobile tracking system offered by Sydion enables healthcare facilities and public health agencies to address the public need by offering a system to track, monitor and administer available vaccines either remotely or on-site.

With eMET, patients are provided with a bar-coded wrist band or other form of identification that includes vital information which is used to create an electronic medical record. The patient ID is entered into the eMET central database, creating a way for medical personnel to track and prioritize all patients, based on individual needs. The system automatically transmits all patient data scanned or entered into the mobile computer to the patients record in the eMET database, ensuring that physicians have up-to-date information and can follow up with the patient as needed.

With increased anticipation around H1N1 vaccination and ongoing outbreaks, it was imperative to find a solution that will allow us to safely and efficiently serve our patients, said Linda McAndrew, RN and Administrative Director, Trauma Program and Emergency Preparedness, Scranton Community Medical Center. Given our previous success using eMET, we are confident that this technology will allow our personnel to effectively administer the H1N1 vaccine, while continuing our focus on providing top quality patient care.

eMET is designed with easy-to-learn technology so all medical staff can quickly adapt to the system, which is extremely vital in emergency situations, said Nina Johnson, Managing Director, Sydion, LCC. We chose Honeywells mobile computers because of their simplicity and durability, allowing medical administrators to stay connected in any type of environment and under most conditions.

The wireless technology and rugged design of Honeywells Dolphin mobile computers gives the units flexibility for use in environments such as schools, offices, and indoor or outdoor locations. With this mobility, healthy patients no longer need to sit in a waiting area with sick patients, as healthcare personnel are able to travel outside of their offices to administer the vaccine. This eliminates exposing healthy patients to the illness, and enables providers to effectively immunize patients while largely reducing transmission of the virus.

For environments that may require a higher level of infection control, eMET is available with Honeywells Dolphin 9900hc mobile computer. The Dolphin 9900hc is equipped with disinfectant-ready housing and is built to withstand frequent cleaning with harsh chemicals. This product allows for maximum cleanliness in any environment, helping to minimize the spread of germs from patient to patient. 

With such a prominent healthcare concern rising around the world, Honeywell is pleased that Sydion selected its Dolphin 9900 mobile computer to be a part of their eMET offering that allows healthcare facilities to manage the process of H1N1 vaccinations, said John Waldron, Vice President of Worldwide Marketing, Honeywell Scanning & Mobility. Through its relationship with Sydion, Honeywell is delivering on its commitment to provide devices that are being used to address the healthcare concerns of today by helping to ensure medical accuracy and increase patient safety.

Comments (0)

Add a Comment

This thread has been closed from taking new comments.

Editorial: +44 (0)1892 536363
Publisher: +44 (0)208 440 0372
Subscribe FREE to the weekly E-newsletter